Hematology

A UCSF study highlights the importance of MRD assessment and clonal diversity in predicting clinical outcomes for multiple myeloma patients

A study has raised awareness about the risk of second primary malignancies in patients treated with chimeric antigen receptor T-cell therapy for hematologic cancers

A new study has highlighted chemokines as potential biomarkers that could enhance the diagnosis and bleeding evaluation in patients with primary immune thrombocytopenia

A study has revealed an increased risk of venous thromboembolism in individuals with sickle cell trait compared to those without the trait.

The latest update to the INWORKS study enhances the understanding of the link between low-dose ionising radiation and mortality from haematological malignancies

A large proportion of adults living with HIV have been found to have anaemia, with several risk factors contributing to its prevalence, according to recent research.

A recent study has found that children with sickle cell disease are at an increased risk of ADHD, with many cases going undiagnosed.

Adding allopurinol to maintenance therapy for paediatric ALL improves outcomes and reduces liver toxicity, even in patients with normal 6-MP metabolism.